Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Julius

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Atherosclerosis. Supplements|December 11, 2019
Actual situation of lipoprotein apheresis in patients with elevated lipoprotein(a) levelsUlrich Julius, Sergey Tselmin, Ulrike Schatz, et al.
Atherosclerosis. Supplements|November 4, 2017
H.E.L.P apheresis exerts long term effects on the capacity of circulating proangiogenic cellsJan Sradnick, Sergey Tselmin, Andrea Wagner, et al.
Atherosclerosis. Supplements|November 4, 2017
Successful and well-tolerated bi-weekly immunoadsorption regimen in pemphigus vulgarisJenny Dietze, Bernd Hohenstein, Sergey Tselmin, et al.
Atherosclerosis. Supplements|January 30, 2013
Lipoprotein apheresis of hypercholesterolemic patients mediates vasoprotective gene expression in human endothelial cellsHenning Morawietz, Winfried Goettsch, Melanie Brux, et al.
Atherosclerosis. Supplements|February 5, 2010
Retinal vessel analysis in hypercholesterolemic patients before and after LDL apheresisManja Reimann, Silke Prieur, Birgit Lippold, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 22, 2019
NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study)Volker Jj Schettler, Florian Muellendorff, Elke Schettler, et al.
Clinical Research in Cardiology Supplements|February 6, 2015
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levelsVolker J J Schettler, Class L Neumann, Christian Peter, et al.
Atherosclerosis. Supplements|December 11, 2019
Cardiovascular risk factors in patients with premature cardiovascular events attending the University of Dresden Lipid ClinicUlrike Schatz, Sabine Fischer, Gabriele Müller, et al.
Diabetes|September 28, 2002
In vivo evidence for increased oxidation of circulating LDL in impaired glucose toleranceSteffi Kopprasch, Jens Pietzsch, Eberhard Kuhlisch, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 5, 2022
Repeated lipoprotein apheresis and immune response: Effects on different immune cell populationsRomy Walther, Rebekka Wehner, Antje Tunger, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Atherosclerosis. Supplements|December 11, 2019
Actual situation of lipoprotein apheresis in patients with elevated lipoprotein(a) levelsUlrich Julius, Sergey Tselmin, Ulrike Schatz, et al.
Atherosclerosis. Supplements|November 4, 2017
H.E.L.P apheresis exerts long term effects on the capacity of circulating proangiogenic cellsJan Sradnick, Sergey Tselmin, Andrea Wagner, et al.
Atherosclerosis. Supplements|November 4, 2017
Successful and well-tolerated bi-weekly immunoadsorption regimen in pemphigus vulgarisJenny Dietze, Bernd Hohenstein, Sergey Tselmin, et al.
Atherosclerosis. Supplements|January 30, 2013
Lipoprotein apheresis of hypercholesterolemic patients mediates vasoprotective gene expression in human endothelial cellsHenning Morawietz, Winfried Goettsch, Melanie Brux, et al.
Atherosclerosis. Supplements|February 5, 2010
Retinal vessel analysis in hypercholesterolemic patients before and after LDL apheresisManja Reimann, Silke Prieur, Birgit Lippold, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|January 22, 2019
NMR-based lipoprotein analysis for patients with severe hypercholesterolemia undergoing lipoprotein apheresis or PCSK9-inhibitor therapy (NAPALI-Study)Volker Jj Schettler, Florian Muellendorff, Elke Schettler, et al.
Clinical Research in Cardiology Supplements|February 6, 2015
Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levelsVolker J J Schettler, Class L Neumann, Christian Peter, et al.
Atherosclerosis. Supplements|December 11, 2019
Cardiovascular risk factors in patients with premature cardiovascular events attending the University of Dresden Lipid ClinicUlrike Schatz, Sabine Fischer, Gabriele Müller, et al.
Diabetes|September 28, 2002
In vivo evidence for increased oxidation of circulating LDL in impaired glucose toleranceSteffi Kopprasch, Jens Pietzsch, Eberhard Kuhlisch, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 5, 2022
Repeated lipoprotein apheresis and immune response: Effects on different immune cell populationsRomy Walther, Rebekka Wehner, Antje Tunger, et al.
Pageof 9